Stockscreener 앱 받기
1.17%
전일 마감가:
$348.62
열려 있는:
$346
하루 거래량:
2.19M
Relative Volume:
0.80
시가총액:
$185.74B
수익:
$36.74B
순이익/손실:
$7.71B
주가수익비율:
24.21
EPS:
14.2333
순현금흐름:
$8.10B
1주 성능:
-3.03%
1개월 성능:
-1.11%
6개월 성능:
+18.09%
1년 성능:
+23.12%
1일 변동 폭
$342.52
$347.66
1주일 범위
$340.06
$356.90
52주 변동 폭
$261.43
$391.29
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
344.55 | 185.74B | 36.74B | 7.71B | 8.10B | 14.23 |
LLY
Lilly Eli Co
|
883.96 | 789.69B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
227.50 | 547.64B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
198.71 | 351.47B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
189.75 | 294.27B | 58.80B | 10.24B | 8.98B | 3.2788 |
NVS
Novartis Ag Adr
|
145.47 | 277.58B | 54.72B | 14.02B | 15.32B | 7.1855 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-21 | 개시 | Canaccord Genuity | Hold |
| 2026-03-10 | 개시 | Jefferies | Hold |
| 2026-02-20 | 개시 | Barclays | Equal Weight |
| 2026-01-20 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-12-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2025-11-24 | 재개 | Truist | Hold |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-09-03 | 재개 | Raymond James | Mkt Perform |
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Amgen Inc. stock (US0311621009): Is its obesity drug pipeline strong enough to unlock new upside? - AD HOC NEWS
Vanguard Group Inc. Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
A Look At Amgen (AMGN) Valuation As New AI Focused Leadership Team Takes Shape - simplywall.st
Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Amgen’s AI-Focused Leadership Reshuffle Could Be A Game Changer For Amgen (AMGN) - Yahoo Finance
Amgen Tracks Long-Term Romosozumab Safety in Children: What Investors Should Know - TipRanks
Amgen Stock (AMGN) Opinions on Q1 Earnings Preview - Quiver Quantitative
Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC - MarketBeat
Amgen Inc. (AMGN) Announces Executive Leadership Transition - GuruFocus
5 Best Stem Cell Therapy Stocks to Buy - Insider Monkey
Wall Street Zen Downgrades Amgen (NASDAQ:AMGN) to Hold - MarketBeat
Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Robert Bradway: Biotech Veteran, Strategic Dealmaker, and Amgen Chairman and CEO - BBN Times
Q1 2026 results announcement pushes Amgen stock down 1.17% - Traders Union
Amgen posts Q1 results April 30; anyone can hear the webcast live - Stock Titan
AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS - Yahoo Finance
Amgen Inc (FRA:AMG0) Stock Price & 30 Year Financial Data - GuruFocus
Merck, Amgen Share Losses Contribute To Dow's 168-Point Drop - Moomoo
Kerusso Capital Management LLC Purchases 3,196 Shares of Amgen Inc. $AMGN - MarketBeat
Quent Long Short Global Small Cap Fund LP Makes New $2.20 Million Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Lessened by OLD National Bancorp IN - MarketBeat
Directional Asset Management Makes New $2.41 Million Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN is China Universal Asset Management Co. Ltd.'s 9th Largest Position - MarketBeat
Amgen Inc. $AMGN Shares Sold by Arizona State Retirement System - MarketBeat
Large-scale manufacturing meets sustainability at Amgen campus in New Albany - Yahoo Finance
Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight - GlobeNewswire Inc.
Amgen Marks Key Milestone With Completion of Early MTAP-Null Cancer Combo Study - TipRanks
David Reese retirement prompts organizational changes at Amgen - The Pharma Letter
Torray Investment Partners LLC Sells 7,883 Shares of Amgen Inc. $AMGN - MarketBeat
Earnings Preview: Amgen (AMGN) Q1 Earnings Expected to Decline - Yahoo Finance UK
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by M&T Bank Corp - MarketBeat
Guggenheim Adjusts Amgen Inc. (AMGN) PT to $351, Cites Updated Model Ahead of Earnings - Insider Monkey
Amgen (AMGN) to Release Earnings on Thursday - MarketBeat
Boston Trust Walden Corp Has $23.54 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Stock Acquired Rep. Maria Elvira Salazar - MarketBeat
Reese retiring after two decades at Amgen - biocentury.com
The Bull Case For Amgen (AMGN) Could Change Following Strong Q4 Beat And Upbeat 2026 Guidance - simplywall.st
Amgen (NASDAQ: AMGN) CTO David Reese to retire as company realigns AI and R&D - Stock Titan
Maria Elvira Salazar makes significant purchases in Amgen, Boeing, and Cisco By Investing.com - Investing.com South Africa
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER - marketscreener.com
Amgen Announces Executive Changes, Effective June 1, 2026 - marketscreener.com
Maria Elvira Salazar makes significant purchases in Amgen, Boeing, and Cisco - Investing.com Canada
AMGN Amgen tops Q4 2025 earnings expectations, posts near 10 percent revenue growth, shares dip 1 percent.Acquisition - Cổng thông tin điện tử tỉnh Lào Cai
AMGQ Bond Risk Analysis - TradingView
Congressional Trading Report: Rep. Maria Elvira Salazar Bought Over $221K In Amgen Stock - Benzinga
Amgen Inc. $AMGN Shares Bought by KLP Kapitalforvaltning AS - MarketBeat
Is Amgen Stock Poised For A Rally? - Trefis
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen Inc. (AMGN)Pre-Earnings Analysis Ahead of Fiscal Q1 2026 Results ReleasePerformance Review - Cổng thông tin điện tử tỉnh Lào Cai
Amgen Faces ERISA Suit Over Health Plan Tobacco Surcharge - Law360
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
암젠 주식 (AMGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Option Exercise |
169.19 |
54,792 |
9,270,143 |
107,119 |
| Santos Esteban | EVP, Operations |
Feb 26 '26 |
Sale |
379.12 |
54,792 |
20,772,595 |
76,618 |
6.88%
2.42%
자본화:
|
볼륨(24시간):